Menu

• Ask a Health Expert about SUTURE RELATED COMPLICATION
• Post Your Side Effect related to SUTURE RELATED COMPLICATION
• SUTURE RELATED COMPLICATION and FDA Warnings
• SUTURE RELATED COMPLICATION in Patients Wiki
• Report SUTURE RELATED COMPLICATION in Drug Side Effect Survey

SUTURE RELATED COMPLICATION side effect

What is SUTURE RELATED COMPLICATION ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Tysabri Side Effects Report #5650069-1
Consumer or non-health professional from UNITED STATES reported TYSABRI problem on Feb 19, 2008. Female patient, 30 years of age, weighting 115.0 lb, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: malignant melanoma, suture related complication, . TYSABRI dosage: 300 MG;QM;IV. During the same period patient was treated with AVIANE. Patient recovered.

Tysabri Side Effects Report #5664290-X
TYSABRI problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 04, 2008. Female patient, 30 years of age, weighting 115.0 lb, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: malignant melanoma, suture related complication, . TYSABRI dosage: 300 MG;QM;IV. During the same period patient was treated with AVIANE. Patient recovered.

Heart Side Effects Report #5584010-7
Health Professional from UNITED STATES reported HEART VALVE problem on Jan 02, 2008. Female patient, 69 years of age, weighting 142.0 lb, was treated with HEART VALVE. After drug was administered, patient experienced the following problems/side effects: post procedural complication, surgical procedure repeated, suture related complication, . HEART VALVE dosage: unknown. Patient recovered.

Bevacizumab Side Effects Report #5759204-8
BEVACIZUMAB problem was reported by a Physician from UNITED KINGDOM on May 20, 2008. Female patient, weighting 190.7 lb, was diagnosed with rectal cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: peritonitis, septic shock, suture related complication, . BEVACIZUMAB dosage: 7.5 MG/KG, Q3W. During the same period patient was treated with OXALIPLATIN, CAPECITABINE, METFORMIN. Patient was hospitalized. Patient recovered.